Creative Planning’s T2 Biosystems, Inc TTOO Stock Holding History

Creative Planning’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1	Closed	-$2K	–	2143
2019 Q1	$2K	Buy	+1	New	+$17K	﹤0.01%	1942

Other funds holding TTOO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

McAdam LLC Philadelphia, Pennsylvania $2.22B AUM 16.98% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Creative Planning's TTOO Position: Q4 2022 in Review

Creative Planning sold out of T2 Biosystems, Inc (TTOO) in Q4 2022, closing a stake of 4 shares — an estimated $2K sold.

Creative Planning first reported a position in TTOO in Q3 2018 and held it in 16 quarters. The position peaked at $112K in Q3 2018. 20 funds tracked by Wall St. Rank hold TTOO as of Q4 2022.

Creative Planning reported no remaining T2 Biosystems, Inc position as of Q4 2022 after selling out during the quarter.
Creative Planning sold 4 T2 Biosystems, Inc shares in Q4 2022, an estimated $2K.
Creative Planning first reported a position in T2 Biosystems, Inc in Q3 2018 and held it in 16 quarters.
Creative Planning's T2 Biosystems, Inc position peaked at $112K in Q3 2018.
20 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2022.

Based on Creative Planning's 13F filing for Q4 2022, filed 10 Feb 2023.